All the Active Ingredient Drugs
Tetanus Toxoid 5 Lf, Diphtheria Toxoid 2 Lf, Pertussis Toxoid 2.5 mcg, Filamentous Haemagglutinin 5 mcg, Pertactin 3 mcg, Fimbriae Types 2+3 5 mcg. Cont. in 0.5 ml :
Diphtheria Toxoid 2 Lf ;Tetanus Toxoid 5 Lf ;
Pertussis Toxoid 2.5 microg; Filamentous Haemagglutinin 5 microg;
Pertactin 3 microg; Fimbriae Types 2 and 3 5 microg;
Aluminium (aluminium phosphate by calc.) 0.33 mg (1.5mg)
VIAL: 1/5/10 x 0.5 ml. susp for I.M. inj. into deltoid musc.
Immun. schedule as per health auth. recommen. Re-dosing at 5-10 years interval. See lit.
Active booster immun. for the prevent. of tetanus, diphtheria and pertussis in childr, adolesc. and adlts aged 4 to 64 years. Not for use as dis. tmt.
C/I:Hypersens. Encephalopathy of unknown origin within 7 days of prev. immuniz. with a pertussis-cont. vacc. To be postponed in persons suffering from an ac. sev. febrile illness. Minor infect. is not a contraind.
Diphtheria Toxoid Not less than 2 IU, Tetanus Immuneglobulin 5 Lf, Pertussis Toxoid 2.5 mcg, Filamentous Haemagglutinin 5 mcg, Fimbriae Types 2+3 5 mcg, Pertactin 3 mcg, Poliomyelitis Virus Type 1 40 D-antigen units, Poliomyelitis Virus Type 2 8 D-antigen units, Poliomyelitis Virus Type 3 32 D-antigen units. PRE-FILLED SYRINGES (susp. for inject.):
1, 10, 20. Starting from age 3, a single
I.M. 0.5 ml dose, in deltoid muscle,
applies to all age groups.
Active booster immunisat. for prevent.
diphth., tetanus, pertussis and polio,
from 3 yrs and over.
C/I: Hypersens., anaphylact./allerg.
reacts. to similar vaccine,
encephalopath. of unknown origin
within 7 days of prev. immunisat. dose
of any vaccine cont. pertussis antigens
(whole cell or acellular). Progress.
neurolog. disords., uncontroll. epilepsy,
progress. encephalopath. until tmt.
regimen established. Febrile or acute
illness. See lit.
